| 臺大學術典藏 |
2020-06-30T08:51:19Z |
Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
|
Kuo K.-L.;Hung S.-C.;Lin Y.-P.;Tang C.-F.;Tzong-Shyuan Lee;Lin C.-P.;Tarng D.-C.; Kuo K.-L.; Hung S.-C.; Lin Y.-P.; Tang C.-F.; TZONG-SHYUAN LEE; Lin C.-P.; Tarng D.-C. |
| 臺大學術典藏 |
2020-06-30T08:51:15Z |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD
|
Kuo K.-L.;Hung S.-C.;Tzong-Shyuan Lee;Tarng D.-C.; Kuo K.-L.; Hung S.-C.; TZONG-SHYUAN LEE; Tarng D.-C. |
| 臺大學術典藏 |
2020-06-30T08:51:13Z |
Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy
|
Chiang C.-W.;Lee H.-T.;Tarng D.-C.;Kuo K.-L.;Cheng L.-C.;Tzong-Shyuan Lee; Chiang C.-W.; Lee H.-T.; Tarng D.-C.; Kuo K.-L.; Cheng L.-C.; TZONG-SHYUAN LEE |
| 臺大學術典藏 |
2020-06-30T08:51:06Z |
Indoxyl sulfate impairs valsartan-induced neovascularization
|
Kuo K.-L.;Zhao J.-F.;Huang P.-H.;Guo B.-C.;Tarng D.-C.;Tzong-Shyuan Lee; Kuo K.-L.; Zhao J.-F.; Huang P.-H.; Guo B.-C.; Tarng D.-C.; TZONG-SHYUAN LEE |
| 臺大學術典藏 |
2020-06-26T03:31:42Z |
Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
|
Wu C.-H.;Yang Y.-W.;Hu Y.-H.;Tsai Y.-C.;Kuo K.-L.;Lin Y.-H.;Hung S.-C.;Wu V.-C.;Wu K.-D.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Huang K.-H.;Chen Y.-M.;Kuo C.-C.;Chang C.-C.;Chueh S.-C.;Lu C.-C.;Shih-Cheng Liao;Yen R.-F.; Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Shih-Cheng Liao; Yen R.-F. |
| 臺大學術典藏 |
2020-03-06T08:25:03Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; YUNG-MING JENG; Huang K.-H.; Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Liu S.-H.;Yung-Ming Jeng;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C. |
| 臺大學術典藏 |
2020-01-23T01:37:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Huang K.-H.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Po-Ming Chow;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2020-01-23T01:37:21Z |
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
|
Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Kuo K.-L.;Lin W.-C.;Huang K.-H.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Kuo K.-L.; Lin W.-C.; Huang K.-H. |
